Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the first patients in the US have been successfully treated ...

The C-reactive protein-triglyceride-glucose index may be a useful biomarker for identifying individuals at elevated risk of ...

Corify Care today announced a major clinical milestone with the publication of two studies in Heart Rhythm and Europace, ...

Corify Care today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the ACORYS® System, ...

RAPIBLYK (R) is an ultra-short-acting, selective beta-1 adrenergic receptor blocker administered intravenously in a monitored hospital setting. Its pharmacological profile allows for rapid onset and ...

FDA approval for RAPIBLYK® (landiolol) for use in pediatric patients with SVT provides first therapeutic option for these ...

Briefs are for businesses in Northwest Arkansas that are new, have moved or closed, opened a new branch, changed owners or have been honored by an independent organization. Also, businesses with ...

Atrial fibrillation is a common but often silent heart condition, especially over 60. Learn the symptoms, risks and why early ...

FDA approval of CARDAMYST represents first new option in 30 years for the more than two million patients with PSVTParticipants using CARDAMYST in ...

Atrial fibrillation, also known as AFib or AF, is a common heart condition that presents as a fast and irregular heartbeat.1 It can be difficult to manage both physically and financially, and can ...